ARCHIVES

Funding opportunities listed.

This article is from The Cancer Letter archive.

Vol. 30 No. 13 | March 26, 2004

Download PDF Visit The Full Archive

Related Articles

An “insurgency” targets randomized trials, demands access to investigational drugs.

August 5, 2005

New Research Ideas In Immodiagnosis Suggested For RFPs

October 21, 1977

NCI Advisory Group, Other Cancer Meetings

November 26, 1976

Shubick Committee Support New System for NCU Review, Action On Chemicals

November 14, 1975

Biotherapeutics Reports LAK/IL-2 Toxicity Reduced With Constant Infusion Of IL-2

April 17, 1987

FDA Considering Ways To Improve Process Of Secondary Approvals Of Cancer Drugs

November 1, 1991